KO vs PMCB · P/E 25, rev $47.94B vs $8.6M cap
The Coca-Cola Company (KO) versus PharmaCyte Biotech Inc (PMCB) — a side-by-side from cached financials, not a winner call.
The Coca-Cola Company (KO) is a beverages - non-alcoholic company listed on NYSE. It is led by James Quincey.
PharmaCyte Biotech Inc (PMCB) is a biotechnology company listed on NASDAQ.
Latest reported KO revenue for 2025-12-31 was $47.94B. Net income was $13.11B. Revenue was up 1.9% from 2024-12-31 to 2025-12-31. KO currently screens at market cap $343.90B and trailing P/E 25.1.
Latest reported PMCB revenue for 2025-04-30 was $0. Net income was $30.7M. PMCB currently screens at market cap $8.6M.
KO currently screens at market cap $343.90B and trailing P/E 25.1. PMCB currently screens at market cap $8.6M.
Not investment advice. Open the KO and PMCB stock pages for the full models.
Not investment advice.